Autologous bone marrow transplantation therapy

Also known as: Autologous bone marrow transplantation / Autologous bone marrow transplant / Autologous bone marrow transplant (procedure)

Drug	Drug Name	Drug Description
DB00020	Sargramostim	A modified form of recombinant human granulocyte-macrophage colony stimulating factor used to increase immune cell production after myelosuppressive therapy or bone marrow transplant.

Drug	Drug Name	Target	Type
DB00020	Sargramostim	Granulocyte-macrophage colony-stimulating factor receptor subunit alpha	target
DB00020	Sargramostim	Bone marrow proteoglycan	target
DB00020	Sargramostim	Interleukin-3 receptor subunit alpha	target
DB00020	Sargramostim	Cytokine receptor common subunit beta	target
DB00020	Sargramostim	Syndecan-2	target

Drug	Drug Name	Phase	Status	Count